Multiple abscesses in a patient treated with cetuximab

Francesco Ricci; Cristina Guerriero; Andrea Paradisi; Barbara Fossati; Francesco Micciche'; Vincenzo Valentini; Rodolfo Capizzi

doi:10.1684/ejd.2012.1889

Multiple abscesses in a patient treated with cetuximab

Francesco Ricci, Cristina Guerriero, Andrea Paradisi, Barbara Fossati, Francesco Micciche', Vincenzo Valentini, Rodolfo Capizzi

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.

Original language	English
Pages (from-to)	103-104
Number of pages	2
Journal	European Journal of Dermatology
Volume	23
DOIs	https://doi.org/10.1684/ejd.2012.1889
Publication status	Published - 2013

Keywords

inglese

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1684/ejd.2012.1889

Cite this

@article{fae1352828984122a7fc4ea737f22ad1,

title = "Multiple abscesses in a patient treated with cetuximab",

abstract = "Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.",

keywords = "inglese, inglese",

author = "Francesco Ricci and Cristina Guerriero and Andrea Paradisi and Barbara Fossati and Francesco Micciche' and Vincenzo Valentini and Rodolfo Capizzi",

year = "2013",

doi = "10.1684/ejd.2012.1889",

language = "English",

volume = "23",

pages = "103--104",

journal = "European Journal of Dermatology",

issn = "1167-1122",

publisher = "John Libby Eurotext Ltd:127 avenue de la Republique, F 92120 Montrouge France:011 33 1 46730660, EMAIL: marketing@jle.com, INTERNET: http://www.john-libbey-eurotext.fr, Fax: 011 33 1 40840999",

}

TY - JOUR

T1 - Multiple abscesses in a patient treated with cetuximab

AU - Ricci, Francesco

AU - Guerriero, Cristina

AU - Paradisi, Andrea

AU - Fossati, Barbara

AU - Micciche', Francesco

AU - Valentini, Vincenzo

AU - Capizzi, Rodolfo

PY - 2013

Y1 - 2013

N2 - Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.

AB - Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.

KW - inglese

UR - http://hdl.handle.net/10807/42038

U2 - 10.1684/ejd.2012.1889

DO - 10.1684/ejd.2012.1889

M3 - Article

SN - 1167-1122

VL - 23

SP - 103

EP - 104

JO - European Journal of Dermatology

JF - European Journal of Dermatology

ER -

Multiple abscesses in a patient treated with cetuximab

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this